医学影像学在肿瘤治疗疗效评价中的应用

隗功华 孙晓光

引用本文:
Citation:

医学影像学在肿瘤治疗疗效评价中的应用

  • 基金项目:

    上海市科委重点项目基金(07JC14039)

The value of medical imaging in tumor therapeutic response

  • 摘要: 磁共振成像、计算机体层成像、核医学显像、超声检查在肿瘤治疗疗效评价中都有一定作用,但各有特点,需要各种影像方法联合评价肿瘤治疗疗效,协助临床医生制定治疗方案、及时修改和调整治疗方案,最大程度地减少或避免治疗的不良反应。
  • [1] Baghi M,Mack MG,Hambek M,at al.Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy.Head Neck,2007,29(2):104-108.
    [2] Muldcr WJ,van der Schaft DW,Hantvast PA,et al.Early in vivo assessment of angiostatic therapy efficacy by molecular MRI.FASEB J,2007,21(2):378-383.
    [3] Khankan AA,Murakami T,Onishi H,et al.Hepatocellular carcinoma treated with radio frequency ablation:an early evaluation with magnetic resonance imaging.J Magn Reson Imaging,2008,27(3):546-551.
    [4] Hayashida Y,Yakushiji T,Awai K,et al.Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image:Initial results.Eur Radiol,2006,16(12):2637-2643.
    [5] Schepkin VD,Lee KC,Kuszpit K,et al.Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance.NMR Biomed,2006,19(8):1035-1042.
    [6] Dyke JP,Sanelli PC,Voss HU,et al.Monitoring the effects of BCNU chemotherapy Wafers (Gliadel) in glioblastema multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla.J Neurooncol,2007,82(1):103-110.
    [7] Oriol A,Valverde D,Capellades J,et al.In vivo quantification of response to treatment in patients with multiple myeloma by 1H magnetic resonance spectroscopy of bone marrow.MAGMA,2007,20(2):93-101.
    [8] Kumar M,Jagannathan NR,Seenu V,et al.Monitoring the therapeutic response of locally advanced breast cancer patients:sequential in vivo proton MR spectroscopy study.J Magn Reson Imaging,2006,24(2):325-332.
    [9] Wile GE,Leyendecker JR,Krehbiel KA,et al.CT and MR imaging after imaging-guided thermal ablation of renal neoplasms.Radiographics,2007,27(2):325-339.
    [10] Makari Y,Yasuda T,Doki Y,et al.Correlation between tumor blood flow assessed by perfusion CT and effect of neoadjuvant therapy in advanced esophageal cancers.J Surg Oncol,2007,96(3):220-229.
    [11] Si Q,Mu H,Yan G,et al.Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler bemodynamics.Hepatagastroenterology,2007,54(74):334-341.
    [12] Si Q,Mu H,Yan G,et al.Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler bemodynamics.Hepatagastroenterology,2007,54(74):334-341.
    [13] Lamuraglia M,Lassau N,Garbay JR,et al.Doppler US with perfusion software and contrast medium injection in the early evaluation of radiofrequency in breast cancer recurrences:a prospective phase II study.EurJ Radiol,2005,56(3):376-381.
    [14] Nabmias C,Hanna WT,Wahl LM,et al.Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT.J Nucl Med,2007,48(5):744-751.
    [15] Berard V,Rousseau JA,Cadorette J,et al.Dynamic imaging of transient metabolic processes by small-animal PET for the evaluation of photosensitizers in photodynamic therapy of cancer.J Nucl Med,2006,47(7):1119-1126.
    [16] Pottgen C,Levegrtin S,Theegarten D,et al.Value of 18F-fluoro-2-deoxy-D-glucose-pesitren emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after necadjuvant chemoradiotherapy.Clin Cancer Res,2006,12(1):97-106.
    [17] Wieder HA,Beer A J,Lordick F,et al.Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction.J Nucl Med,2005,46(12):2029-2034.
    [18] Rousseau C,Devillers A,Sagan C,et al.Monitoring of early response to neoadjuvant chemotherapy in stage Ⅱ and Ⅲ breast cancer by[18F]fluorodeoxyglucose positron emission tomography.J Clin Oncel,2006,24(34):5366-5372.
    [19] Goshen E,Davidsen T,Zwas ST,et al.PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan.Tecbol Cancer Res Treat,2006,5(1):37-43.
    [20] Bleichner-Perez S,Le Jeune F,Duhais F,et al.99mTc-MIBI brain SPECT as an indicator of the chemotherapy response of recurrent,primary brain tumors.Nucl Med Commun,2007,28(12):888-894.
    [21] Akgun A,Cok G,Karapolat I,et al.99mTc-MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.Ann Nucl Med,2006,20(4):269-275.
  • [1] 赵晋华郭慧敏 . 综合应用临床影像学对乳腺癌进行筛查、诊断和分期. 国际放射医学核医学杂志, 2009, 33(4): 222-225. doi: 10.3760/cma.j.issn.1673-4114.2009.04.009
    [2] 郭慧敏赵晋华 . 应用影像学方法评价乳腺癌新辅助化疗疗效. 国际放射医学核医学杂志, 2009, 33(3): 149-153. doi: 10.3760/cma.j.issn.1673-4114.2009.03.006
    [3] 冯学民 . 甲状腺癌的影像学研究进展. 国际放射医学核医学杂志, 2006, 30(5): 275-280.
    [4] 董华张遵城 . 眼眶海绵状血管瘤的影像学分析. 国际放射医学核医学杂志, 2008, 32(1): 55-57,62.
    [5] 卢晓莉张俊王峰王自正 . 影像学技术对转移性淋巴结的诊断价值. 国际放射医学核医学杂志, 2011, 35(6): 334-338. doi: 10.3760,cma.j.issn.1673-4114.2011.06.004
    [6] 叶慧莫逸谢爱民彭翔18F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究. 国际放射医学核医学杂志, 2008, 32(3): 147-150.
    [7] 王静姚振威 . 细胞磁共振成像技术在体示踪免疫细胞的研究进展. 国际放射医学核医学杂志, 2014, 38(5): 337-340. doi: 10.3760/cma.j.issn.1673-4114.2014.05.014
    [8] 马彦云张辉 . 磁共振体素内不相干运动扩散加权成像的原理及应用进展. 国际放射医学核医学杂志, 2016, 40(6): 469-473. doi: 10.3760/cma.j.issn.1673-4114.2016.06.013
    [9] 宋建华赵晋华邢岩 . 胸、腹部肿瘤PET-CT扫描方案的设置与选择. 国际放射医学核医学杂志, 2007, 31(6): 349-353.
    [10] 张璐詹维伟张一帆 . 颈部超声在分化型甲状腺癌131I治疗中的应用进展. 国际放射医学核医学杂志, 2014, 38(4): 271-274. doi: 10.3760/cma.j.issn.1673-4114.2014.04.015
  • 加载中
计量
  • 文章访问数:  1606
  • HTML全文浏览量:  183
  • PDF下载量:  3
出版历程
  • 收稿日期:  2008-07-24

医学影像学在肿瘤治疗疗效评价中的应用

  • 上海交通大学医学院附属仁济医院核医院, 上海 200127
基金项目:  上海市科委重点项目基金(07JC14039)

摘要: 磁共振成像、计算机体层成像、核医学显像、超声检查在肿瘤治疗疗效评价中都有一定作用,但各有特点,需要各种影像方法联合评价肿瘤治疗疗效,协助临床医生制定治疗方案、及时修改和调整治疗方案,最大程度地减少或避免治疗的不良反应。

English Abstract

参考文献 (21)

目录

    /

    返回文章
    返回